7799 results
-
List item
Human medicine European public assessment report (EPAR): Darunavir Mylan
darunavir, HIV Infections
Date of authorisation: 03/01/2017,
, Revision: 13, Authorised, Last updated: 23/05/2023
Darunavir Mylan Blood-Borne Infections Communicable … report (EPAR) for Darunavir Mylan. It explains how the Agency … advice on how to use Darunavir Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Mylan
docetaxel, Head and Neck Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Prostatic Neoplasms; Breast Neoplasms
Date of authorisation: 31/01/2012,, Revision: 6, Withdrawn, Last updated: 12/03/2015
Docetaxel Mylan Head and Neck Neoplasms Carcinoma … oduct details Name Docetaxel Mylan Agency product number EMEA/H/C/002317 … chemical (ATC) code L01CD02 Generic Generic Generic This is a … -
List item
Human medicine European public assessment report (EPAR): Sugammadex Mylan
sugammadex sodium, Neuromuscular Blockade
Date of authorisation: 15/11/2021,, Revision: 2, Authorised, Last updated: 21/06/2023
Sugammadex Mylan Protective Agents Specialty … sugammadex Overview Sugammadex Mylan is a medicine used to reverse … the operation. Sugammadex Mylan is used to speed up the recovery … -
List item
Human medicine European public assessment report (EPAR): Fingolimod Mylan
fingolimod hydrochloride , Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 18/08/2021,, Revision: 4, Authorised, Last updated: 02/05/2023
Fingolimod Mylan Multiple Sclerosis, Relapsin … fingolimod Overview Fingolimod Mylan is a medicine used to treat … remissions). Fingolimod Mylan is used when the disease … -
List item
Human medicine European public assessment report (EPAR): Anagrelide Mylan
Anagrelide hydrochloride, Thrombocythemia, Essential
Date of authorisation: 15/02/2018,, Revision: 8, Authorised, Last updated: 11/05/2023
Anagrelide Mylan Cancer Neoplasms Blood … report (EPAR) for Anagrelide Mylan. It explains how the Agency … on how to use Anagrelide Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Memantine Mylan
memantine hydrochloride, Alzheimer Disease
Date of authorisation: 21/04/2013,, Revision: 10, Authorised, Last updated: 29/03/2023
Memantine Mylan Nervous System Diseases Central … report (EPAR) for Memantine Mylan. It explains how the Agency … advice on how to use Memantine Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Rasagiline Mylan
rasagiline tartrate, Parkinson Disease
Date of authorisation: 04/04/2016,, Revision: 7, Authorised, Last updated: 23/02/2023
Rasagiline Mylan Nervous System Diseases Central … report (EPAR) for Rasagiline Mylan. It explains how the Agency … on how to use Rasagiline Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Cinacalcet Mylan
cinacalcet hydrochloride, Hyperparathyroidism, Secondary; Hypercalcemia
Date of authorisation: 19/11/2015,, Revision: 15, Authorised, Last updated: 26/04/2023
Cinacalcet Mylan Nutritional and Metabolic … report (EPAR) for Cinacalcet Mylan. It explains how the Agency … on how to use Cinacalcet Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Entecavir Mylan
entecavir monohydrate, Hepatitis B
Date of authorisation: 18/09/2017,, Revision: 6, Authorised, Last updated: 19/04/2023
Entecavir Mylan Infections Communicable … report (EPAR) for Entecavir Mylan. It explains how the Agency … advice on how to use Entecavir Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Pregabalin Mylan Pharma
pregabalin, Anxiety Disorders; Neuralgia; Epilepsy
Date of authorisation: 25/06/2015,, Revision: 7, Withdrawn, Last updated: 26/04/2022
Pregabalin Mylan Pharma Mental Disorders Nervous … authorisation for Pregabalin Mylan Pharma has been withdrawn … Summary documents Pregabalin Mylan Pharma : EPAR - Summary for … -
List item
Withdrawn application: Alendronic Acid / Colecalciferol Mylan
date of withdrawal: 27/05/2016, Initial authorisation, Last updated: 02/02/2017dronic Acid / Colecalciferol Mylan: Withdrawn application … Questions and answers on generic medicines What is a generic medicine? A generic medicine is a medicine that … dronic Acid / Colecalciferol Mylan Alendronic Acid / Colecalciferol … -
List item
Human medicine European public assessment report (EPAR): Prasugrel Mylan
prasugrel besilate, Myocardial Infarction; Acute Coronary Syndrome; Angina, Unstable
Date of authorisation: 15/05/2018,, Revision: 8, Authorised, Last updated: 28/06/2022
Prasugrel Mylan Cardiovascular Diseases Heart … Prasugrel Mylan is taken together with aspirin … supplying the heart. Prasugrel Mylan contains the active substance … -
List item
Human medicine European public assessment report (EPAR): Abiraterone Mylan (updated)
abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 20/08/2021,, Revision: 4, Authorised, Last updated: 11/09/2023
Abiraterone Mylan Cancer Neoplasms Genital … acetate Overview Abiraterone Mylan is a cancer medicine used … metastatic). Abiraterone Mylan is used together with prednisone … -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Mylan
zoledronic acid, Fractures, Bone
Date of authorisation: 23/08/2012,, Revision: 14, Authorised, Last updated: 20/04/2023
Zoledronic acid Mylan Wounds and Injuries Fractures … EPAR) for Zoledronic acid Mylan. It explains how the Committee … of use for Zoledronic acid Mylan. What is Zoledronic acid Mylan? Zoledronic acid Mylan is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Dimethyl fumarate Mylan (updated)
dimethyl fumarate, Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 13/05/2022,, Revision: 4, Authorised, Last updated: 08/09/2023
Dimethyl fumarate Mylan Nervous System Diseases Autoimmune … Dimethyl fumarate Mylan is a medicine used to treat … remissions). Dimethyl fumarate Mylan contains the active substance … -
List item
Human medicine European public assessment report (EPAR): Tenofovir disoproxil Mylan
tenofovir disoproxil, HIV Infections
Date of authorisation: 08/12/2016,, Revision: 18, Authorised, Last updated: 20/09/2022
Tenofovir disoproxil Mylan Blood-Borne Infections Communicable … for Tenofovir disoproxil Mylan. It explains how the Agency … use Tenofovir disoproxil Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Lopinavir/Ritonavir Mylan
lopinavir, ritonavir, HIV Infections
Date of authorisation: 14/01/2016,, Revision: 16, Authorised, Last updated: 25/05/2023
Lopinavir/Ritonavir Mylan Blood-Borne Infections Communicable … EPAR) for Lopinavir/Ritonavir Mylan. It explains how the Agency … to use Lopinavir/Ritonavir Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Arsenic trioxide Mylan
Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 01/04/2020,, Revision: 4, Authorised, Last updated: 29/03/2023
Arsenic trioxide Mylan Cancer Neoplasms Leukemia … Arsenic trioxide Mylan is used to treat adults (aged … vitamin A). Arsenic trioxide Mylan is used in: patients with … -
List item
Human medicine European public assessment report (EPAR): Atazanavir Mylan
atazanavir (as sulfate), HIV Infections
Date of authorisation: 22/08/2016,, Revision: 14, Authorised, Last updated: 17/05/2023
Atazanavir Mylan Immunologic Deficiency Syndromes Immune … report (EPAR) for Atazanavir Mylan. It explains how the Agency … on how to use Atazanavir Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Amlodipine / Valsartan Mylan
Amlodipine besilate, valsartan, Hypertension
Date of authorisation: 22/03/2016,, Revision: 11, Authorised, Last updated: 17/08/2023
Amlodipine / Valsartan Mylan Cardiovascular Diseases Vascular … for Amlodipine/Valsartan Mylan. It explains how the Agency … use Amlodipine/Valsartan Mylan. For practical information … -
List item
Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) (updated)
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 30/06/2015,, Revision: 16, Authorised, Last updated: 08/09/2023
Aripiprazole Mylan Pharma (previously Aripiprazole … report (EPAR) for Aripiprazole Mylan Pharma. It explains how the … on how to use Aripiprazole Mylan Pharma. For practical information … -
List item
Human medicine European public assessment report (EPAR): Ribavirin Mylan (previously Ribavirin Three Rivers)
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 10/06/2010,, Revision: 10, Withdrawn, Last updated: 23/11/2020
Ribavirin Mylan (previously Ribavirin Three … oduct details Name Ribavirin Mylan (previously Ribavirin Three … chemical (ATC) code J05AB04 Generic Generic Generic This is a … -
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan
emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 16/12/2016,, Revision: 14, Authorised, Last updated: 27/07/2023
itabine/Tenofovir disoproxil Mylan Blood-Borne Infections Communicable … Emtricitabine/Tenofovir disoproxil Mylan is an HIV medicine that is … Emtricitabine/Tenofovir disoproxil Mylan is also used to help prevent … -
List item
Human medicine European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan
sitagliptin hydrochloride monohydrate, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 16/02/2022,, Revision: 2, Authorised, Last updated: 30/05/2023
Metformin hydrochloride Mylan Diabetes Mellitus Endocrine … Sitagliptin/Metformin hydrochloride Mylan is a medicine used to control … Sitagliptin/Metformin hydrochloride Mylan contains the The substance … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel / Acetylsalicylic acid Mylan
Acetylsalicylic acid, clopidogrel hydrogen sulfate, Acute Coronary Syndrome; Myocardial Infarction
Date of authorisation: 09/01/2020,, Revision: 4, Authorised, Last updated: 02/08/2022
ogrel / Acetylsalicylic acid Mylan Cardiovascular Diseases Heart … Clopidogrel/Acetylsalicylic acid Mylan is a medicine used to prevent … Clopidogrel/Acetylsalicylic acid Mylan contains two The substance …